Interestingly, one patient, whose epitope reactivity was negative at baseline and became an epitope spreader at the 6th month, suffered from persistent nephrotic syndrome and treatment resistance, despite a relatively low anti-PLA2R antibody titer. The gene discussed is PLA2R1; the disease is nephrotic syndrome.